Organon (OGN) Share-based Compensation (2020 - 2026)

Organon has reported Share-based Compensation for 7 years, with the latest figure at $25.0 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 13.64% year-over-year to $25.0 million in Q2 2026; TTM through Jun 2026 was $75.0 million, a 22.68% decrease from a year earlier, with the FY2025 full-year figure at $77.0 million, down 45.39% from the prior year.
• Share-based Compensation was $25.0 million for Q2 2026 at Organon, up from $19.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $28.0 million in Q2 2024, with the low at $7.0 million in Q4 2025.
• Average Share-based Compensation over 5 years is $22.3 million, with a median of $24.0 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation surged 53.33% in 2022, then tumbled 73.08% in 2025.
• Over 5 years, Share-based Compensation stood at $23.0 million in 2022, then climbed by 17.39% to $27.0 million in 2023, then retreated by 3.7% to $26.0 million in 2024, then slumped by 73.08% to $7.0 million in 2025, then surged by 257.14% to $25.0 million in 2026.
• The last three Share-based Compensation figures came in at $25.0 million (Q2 2026), $19.0 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.